Brent Willis is CEO of Voyageur Pharmaceuticals Ltd., building a new pharmaceutical industry in Western Canada. Voyageur owns three barium projects in B.C., including one with a resource estimate, Iodine properties in Utah, has a Joint Venture with privately held Chief Medical Supplies Ltd. (a Canadian pharmaceutical manufacturing and distribution company) to manufacture and market contrast agents (made with barium and/or iodine compounds) used for radiology digital imaging in the healthcare industry. In this podcast, Brent discusses the challenges of operating his business during the COVID-19 pandemic and how remote working actually increased efficiency and will become the new norm for his business.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related